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Abstract. Pancreatic cancer is the fourth leading cause of
cancer‑associated mortality. The major risk factor for pancreatic
cancer is cigarette smoking. Kras mutations are commonly
observed in human pancreatic cancers. The present study
examined the hypothesis that exposure to cigarette smoke and
overexpression of a mutant Kras gene in the pancreas affects
pancreatic cell proliferation in mice. Mice overexpressing the
mutant Kras gene (KRasG12D) in the pancreas as well as wild‑type
mice were exposed to environmental tobacco smoke for 2 weeks.
Overexpression of mutant Kras increased cell proliferation in
pancreatic ductal, acinar and islet cells. Notably, cigarette smoke
exposure decreased cell proliferation in pancreatic ductal and
acinar cells, and had no effect in islet cells. Cigarette smoke
did not affect pancreatic protein levels of tumor necrosis factor
(TNF)α, p53, or cyclin D1, but mutant Kras overexpression
slightly decreased TNFα and p53 protein levels. Therefore,
pancreatic cell proliferation in mice overexpressing mutant Kras
is associated with the later development of pancreatic tumors,
but effects of cigarette smoke on pancreatic cell proliferation do
not provide a good model for human pancreatic carcinogenesis.
Introduction
Pancreatic cancer is the tenth most common form of cancer, and
is the fourth leading cause of cancer‑associated mortality (1).
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Pancreatic cancer is one of the deadliest forms of cancer, with a
5‑year survival rate of only 4.4%.
A number of risk factors have been identified for pancreatic cancer, including gender, ethnicity and history of chronic
pancreatitis (2). The greatest environmental risk factor for
pancreatic cancer is cigarette smoking (2). The relative risk for
cigarette smoking is between 2 and 3 fold, but can be higher in
heavy smokers, suggesting a dose‑response association (2). It is
not clear how cigarette smoke contributes to pancreatic cancer
development. Components of cigarette smoke likely reach the
pancreas through the general circulation, but also may come
from the GI tract through reflux. The chemical component(s) of
cigarette smoke that are responsible for increasing pancreatic
cancer risk are not known, although some evidence supports
a role for aromatic amines or N‑nitroso compounds (2). The
molecular mechanisms of the enhancement of pancreatic cancer
by cigarette smoke are not understood.
One approach to understanding the molecular mechanisms of pancreatic cancer development is to use animal
models. Several chemical carcinogenesis models exist (3).
A transgenic model has been developed, which uses
an oncogenic Kras (KRas G12D) inserted into the endogenous Kras locus (4). The gene has a Lox‑STOP‑Lox (LSL)
construct inserted upstream. These mice are interbred with
mice containing the Cre recombinase downstream from
a pancreatic specific promoter, either PDX‑1 or P48. The
PDX‑1‑Cre;LSL‑KRasG12D mice develop pancreatic intraepithelial neoplasias (PanINs), which progress over time (4). In
addition, when these mice are crossed to mice containing p53
mutations or Ink4a/Arf deficiency, the rapid development of
pancreatic adenocarcinomas is observed (5,6).
The present study examined the hypothesis that exposure
to cigarette smoke or overexpression of the oncogenic Kras
oncogene would affect cell proliferation in the pancreas in mice.
PDX‑1‑Cre; LSL‑KRasG12D and wild‑type mice were exposed to
cigarette smoke for 2 weeks. It has been observed previously that
a 5‑day exposure to cigarette smoke is sufficient to increase cell
proliferation in the lung (7,8). Mice were treated with bromodeoxyuridine (BrdU) during the exposure period, and the rate
of cell proliferation and gene expression associated with cell
proliferation were examined.
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Table I. Results of two‑way analysis of variance for the study endpoints.

Study
endpoint
Final body weight
Ductal cell LI
Acinar cell LI
Islet cell LI
TNFα
P53
Cyclin D1

P‑values
‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑
Main effect for
Main effect for
Smoke/Kras
smoke exposurea
Kras overexpressionb
interaction
0.033
0.016
0.013
0.72
0.58
0.59
0.39

0.41
<0.001
<0.001
<0.001
0.10
0.090
0.38

0.27
0.12
0.28
0.066
0.84
0.75
0.89

vs. non‑smoke exposure group; bvs. wild‑type Kras expression group. LI, labeling index; TNF, tumor necrosis factor.

a

Materials and methods
Experimental design. PDX‑1‑Cre and LSL‑KRASG12D mice were
obtained from the National Cancer Institute Mouse Repository
(Frederick, MD, USA). The two strains were bred to obtain 16
PDX‑1‑Cre; LSL‑KRASG12D mice. PDX‑1‑Cre‑positive mice
were used as controls. Male 9‑10 week old mice were used.
Half of the mice in each group were exposed to cigarette smoke
for a period of 2 weeks. In total, 7‑8 mice were in each of the
4 groups, with a total of 30 mice. An inhalation exposure to
smoke was performed in a whole‑body Hinners type stainless steel/glass chamber, as previously described (9). Cigarette
smoke was generated from 3R4F University of Kentucky
(Lexington, KY, USA) research cigarettes. The concentration of
smoke particulates in the exposure chamber atmosphere averaged 46±3 mg TPM/m3. The mice received smoke exposure for
a total of 6 h each day, 5 days per week, Monday to Friday, for
2 weeks (10 days total exposure). Mice were euthanized 3 days
after the last exposure (the next Monday morning). Mice were
administered BrdU in the drinking water (0.5 mg/ml), starting
at the same time as smoke exposure, and continuing until they
were euthanized. Subsequently, the pancreas was split into two
pieces, with one half fixed in buffered neutral formalin (and
subsequently processed to paraffin blocks) and the other half
flash frozen in liquid nitrogen, and then stored at ‑80˚C.
Analysis of cell proliferation. Subsequent to fixation and
processing, 5‑µm sections were prepared from the paraffin
blocks. The sections of paraffin‑embedded tissue samples were
deparaffinized, thoroughly washed in water, and then placed
in 3% H2O2 in methanol for 10 min. The sections were then
stained immunohistochemically by the avidin‑biotin‑peroxidase complex method using Vectastain ABC reagent (Vector
Laboratories, Burlingame, CA, USA), with mouse anti‑BrdU
monoclonal antibodies (cat. no. 555627; BD Biosciences,
Franklin Lakes, NJ, USA), at 100 µl/slide using a 1:40 dilution
of BrdU. The reaction product was then visualized using diaminobenzidine (Vector Laboratories Peroxidase Substrate kit) and
the slides were counterstained with hematoxylin. Having brown
nuclei identified cells that had incorporated BrdU. Labeling
indexes were determined for the following 3 regions in the

pancreas: ductal, acinar and islet cells. In total, 500 cells per
slide were counted and labeling indexes were determined.
Western blot analysis. Levels of tumor necrosis factor (TNF)
a, p53 and cyclin D1 proteins in pancreas homogenates were
determined by western analyses. Antibodies were obtained
from Santa Cruz Biotechnology (Dallas, TX, USA). The frozen
pancreases were homogenized in extraction buffer (Pierce
Biotechnology, Inc., Rockford, IL, USA) containing protease
inhibitors (Sigma‑Aldrich; Merck Millipore, Darmstadt,
Germany). Lysed tissue was centrifuged at 8,000 x g for 30 min
at 4˚C. Protein levels of the supernatants were determined by
bicinchoninic acid assay (Pierce Biotechnology, Inc.) and stored
at ‑80˚C. Protein samples (30 µg per treatment) were separated
using 10% SDS‑PAGE and subsequently were transferred onto
nitrocellulose membranes. Membranes were blocked with 5%
non‑fat milk buffer and incubated overnight at 4˚C with primary
antibodies. Subsequent to washing, membranes were incubated with secondary antibodies conjugated with horseradish
peroxidase and visualized using enhanced chemiluminescence
detection reagents (Thermo Fisher Scientific Inc., Waltham, MA,
USA). Bands were quantified using ImageJ software (National
Institutes of Health, Bethesda, MD, USA) and normalized to
β‑actin expression.
Statistical analysis. Results were first analyzed by two‑way
analysis of variance (ANOVA), using Sigmaplot for Windows
(version 13.0; Systat Software, Inc., San Jose, CA). If significant
interactions were identified, differences between means were
determined using the Holm‑Sidak post‑hoc test. The results are
reported as the mean ± standard error of the mean. P≤0.05 was
considered to indicate a statistically significant difference. The
results of the ANOVAs are shown in Table I.
Results
The present study examined the effects of mutant Kras
overexpression and smoke exposure on pancreatic cell proliferation and associated gene expression. Mice were exposed to
sidestream tobacco smoke for 2 weeks. Mutant Kras overexpression did not affect body weights, but short‑term cigarette
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Figure 1. Labeling indices in pancreatic (A) ductal, (B) acinar and (C) islet cells. Results are expressed as the mean ± standard error, with n=7 or 8. *Significant
differences due to mutant Kras overexpression are indicated with an asterisk; ^significant differences in smoke‑exposed mice (P<0.05). Cre, Cre recombinase.

Figure 2. (A) The western blot analysis shows expression of TNF‑α, p53, cyclin D1 and β‑actin in pancreas tissue lysates (A). The graphs show quantitative
analysis of protein expression for (B) TNF‑α, (C) p53, and (D) cyclin D1 using ImageJ. β‑actin was used as the loading control. Results are expressed as the
mean ± standard error, with n=3 or 4. TNF‑α, tumor necrosis factor α; R, Kras; C/Cre, Cre recombinase; AU, arbitrary unit.

smoke exposure significantly reduced body weights (P=0.033;
data not shown). Mice were administered BrdU in the drinking

water, and then labeling indexes of BrdU‑stained nuclei were
used to quantify cell proliferation. Cell proliferation in ductal
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cells, from which the majority of human pancreatic cancers
are derived, was increased (P<0.001) in mice overexpressing
mutant Kras; however, cigarette smoke exposure decreased
(P= 0.016) cell proliferation (Fig. 1). In acinar cells, cell
proliferation was similarly increased (P<0.001) by mutant
Kras overexpression and decreased (P= 0.013) by cigarette
smoke exposure. In islet cells, cell proliferation was increased
(P<0.001) by mutant Kras overexpression, but not affected by
cigarette smoke exposure.
Subsequently, the levels of several proteins in the pancreas
that could be affecting cell proliferation and tumorigenesis
were examined. TNFα is a pro‑inflammatory cytokine that
may have promoting or inhibitory effects in pancreatic carcinogenesis (10). p53 is a tumor suppressor gene that promotes
apoptosis but also inhibits cell proliferation (11). Cyclin D1
regulates cyclin‑dependent kinases (CDKs), which increase
cell proliferation (12). Neither cigarette smoke exposure nor
Kras overexpression, however, significantly affected the protein
levels of TNFα, p53, or cyclin D1 in the pancreas (Fig. 2). Kras
overexpression slightly, but not significantly, decreased the
protein levels of TNFα (P=0.10) and p53 (P=0.09).
Discussion
In the present study, it was observed that Kras overexpression
increased but cigarette smoke exposure decreased cell proliferation in pancreatic ductal cells, the cell type from which
most human pancreatic cancers are derived. It was observed
that cigarette smoke induced decreases in cell proliferation in
pancreatic ductal cells and acinar cells but had no effect in
islet cells. A previous study has quantified cell proliferation in
response to cigarette smoke; Wisniewska et al (13) observed
inconsistent effects of cigarette smoke. Wisniewska et al (13),
however, did not differentiate between the different types of
pancreatic cells. Cigarette smoke was found not to promote
7,12‑dimethylbenzanthracene‑induced pancreatic carcinogenesis in mice (14). Cell proliferation was increased in the
lung after short‑term exposure to cigarette smoke in several
studies (7,8,15,16). In other studies examining cell proliferation in the pancreas, Xue et al (17) found that diets high in fat
and phosphorus and low in calcium and vitamin D increased
cell proliferation in pancreatic ductal and acinar cells.
Ledda‑Columbano et al (18) found that the administration
of thyroid hormone increased cell proliferation in pancreatic
acinar cells.
The present study observed that the expression of a mutant
Kras oncogene in the pancreas increased cell proliferation in
ductal, acinar and islet cells. The expression of this oncogene
has previously been shown to induce PanINs and pancreatic
tumors (4). The expression of the mutant Kras produces
metabolic changes that are supportive of an increase in cell
proliferation (19).
Neither KrasG12D nor smoke exposure significantly affected
the levels of three proteins that could affect cell proliferation.
One factor could have been that whole pancreas was used in
the analysis, which could have prevented the observation of
changes in individual cell types. KrasG12D's inhibitory effect
on p53 protein levels is consistent with the effect of p53 on
increasing apoptosis but inhibiting cell proliferation (11). TNFα
has been found to increase pancreatic cell proliferation (20,21);

therefore, it is not clear how Kras inhibition of TNFα contributes to the increase in cell proliferation observed in the mutant
Kras mice.
In summary, the present mouse model does not appear to be
a good model for cigarette smoke‑induced human pancreatic
carcinogenesis. Cigarette smoking is the number one environmental risk factor for human pancreatic cancer. Therefore, the
inhibition of pancreatic ductal and acinar cell proliferation
by smoke exposure in the present study is not associated with
smoke effects on humans. It would be expected that decreased
cell proliferation would be protective against pancreatic carcinogenesis.
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